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Oxygen Glucose Deprivation in Rat Hippocampal Slice
Cultures Results in Alterations in Carnitine Homeostasis
and Mitochondrial Dysfunction
Thomas F. Rau1, Qing Lu2, Shruti Sharma2, Xutong Sun2, Gregory Leary1, Matthew L. Beckman1,
Yali Hou2, Mark S. Wainwright3, Michael Kavanaugh1, David J. Poulsen1*, Stephen M. Black2*
1 Department of Biomedical and Pharmaceutical Sciences, University of Montana, Missoula, Montana, United States of America, 2 Vascular Biology Center, Medical College
of Georgia, Augusta, Georgia, United States of America, 3 Department of Pediatrics, Northwestern University Feinberg School of Medicine, Children’s Memorial Hospital,
2300 Children’s Plaza, Chicago, Illinois, United States of America

Abstract
Mitochondrial dysfunction characterized by depolarization of mitochondrial membranes and the initiation of mitochondrialmediated apoptosis are pathological responses to hypoxia-ischemia (HI) in the neonatal brain. Carnitine metabolism directly
supports mitochondrial metabolism by shuttling long chain fatty acids across the inner mitochondrial membrane for betaoxidation. Our previous studies have shown that HI disrupts carnitine homeostasis in neonatal rats and that L-carnitine can
be neuroprotective. Thus, this study was undertaken to elucidate the molecular mechanisms by which HI alters carnitine
metabolism and to begin to elucidate the mechanism underlying the neuroprotective effect of L-carnitine (LCAR)
supplementation. Utilizing neonatal rat hippocampal slice cultures we found that oxygen glucose deprivation (OGD)
decreased the levels of free carnitines (FC) and increased the acylcarnitine (AC): FC ratio. These changes in carnitine
homeostasis correlated with decreases in the protein levels of carnitine palmitoyl transferase (CPT) 1 and 2. LCAR
supplementation prevented the decrease in CPT1 and CPT2, enhanced both FC and the AC:FC ratio and increased slice
culture metabolic viability, the mitochondrial membrane potential prior to OGD and prevented the subsequent loss of
neurons during later stages of reperfusion through a reduction in apoptotic cell death. Finally, we found that LCAR
supplementation preserved the structural integrity and synaptic transmission within the hippocampus after OGD. Thus, we
conclude that LCAR supplementation preserves the key enzymes responsible for maintaining carnitine homeostasis and
preserves both cell viability and synaptic transmission after OGD.
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transporters further exacerbating ATP depletion leading to
necrotic and/or apoptotic cell death [2,3,4,5].
A crucial mitochondrial system disrupted by HI is the carnitine
pathway [6]. Carnitine facilitates the transport of long chain fatty
acids from the cytosol across the mitochondrial matrix for
metabolism via beta-oxidation and their utilization in the citric
acid cycle [7,8,9] Carnitine palmitoyl transferase 1 (CPT1),
carnitine acylcarnitine translocase, and carnitine palmitoyl transferase 2 (CPT2) are the 3 key transporters that shuttle fatty acids
into the mitochondria as long-chain fatty acylcarnitine esters [7,9].
Once inside the mitochondrial matrix carnitine removes toxic fatty
acyl-CoA metabolites and supplements a pool of free CoA that is
actively utilized to maintain acyl-CoA/free CoA homeostasis.
During HI, mitochondrial dysfunction causes an accumulation of
acyl-CoA moieties that inhibit glycolysis, gluconeogenesis, the
citric acid cycle, fatty acid, and protein catabolism [4,10]. We have
previously shown that carnitine homeostasis is disrupted by HI [6]
and that the administration of L-carnitine (LCAR) to neonatal rat
pups resulted in significant decreases in infarct size 7- and 28-days

Introduction
Neonatal hypoxic-ischemic encephalopathy (HIE) is a pathological condition that occurs in 1–6 per 1000 live births and results in
significant neurodevelopmental disabilities in affected infants [1,2].
Neonatal HIE occurs when cerebral blood flow is significantly
impaired before, during, or immediately after parturition,
rendering the brain ischemic. If the ischemia persists, HIE will
occur leading to seizures, blindness, severe cognitive deficits, and
cerebral palsy characterized by hemiplegia, paraplegia, or
quadriplegia [1]. At a molecular level, neonatal ischemia increases
glutamate release activating NMDA, AMPA, and kainate
receptors elevating cytosolic Ca2+. As Ca2+ levels increase
mitochondrial buffering is overwhelmed, Ca2+ is spontaneously
released, and the mitochondrial permeability transition pore
(MPTP) is activated [3]. MPTP activation depolarizes the
mitochondria resulting in a loss of ATP production, an increase
in reactive oxygen species (ROS) and damage to cytochromes in
the electron transport chain [4]. The increased presence of ROS
and Ca2+ within the mitochondria also disrupts key enzymes and
PLOS ONE | www.plosone.org
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plates for 6 days at 37uC in 5% CO2. For the first two days, the
slices were maintained in a primary plating media (50% DMEM,
25% HBSS, 25% heat inactivated horse serum, 5 mg/mL Dglucose (Sigma), 1 mM Glutamax, 1.5% PenStrep/Fungizone
(Invitrogen), and 5 mL of 50X B27 supplement plus anti-oxidants
(Invitrogen). On the fourth day in culture, slices were placed in
serum-free neurobasal medium (10 mL Neurobasal-A, 200 mL of
50X B27 supplement, 100 mL of 100X Fungizone, and 100 mL of
100X Glutamax). Twenty-four hours prior to experimentation
(day 6), the inserts were placed in serum-free neurobasal A media
and B27 supplement without antioxidants. Two hours prior to the
induction of oxygen-glucose deprivation (OGD), slices were
treated with LCAR (5 mM) dissolved in serum-free neurobasal
A media and B27 supplement without antioxidants. A glucose free
balanced salt solution (BSS) (120 mM NaCl, 5 mM KCl,
1.25 mM NaH2PO4, 2 mM MgSO4, 2 mM CaCl2, 25 mM
NaHCO3, 20 mM HEPES, 25 mM sucrose pH of 7.3) was
infused for 1 h with 5% CO2/95% nitrogen at approximately
10 L/h. Deoxygenated BSS was placed in a 6 well plate and
warmed in a Pro-Ox chamber for 15 minutes with an oxygen
feedback sensor that maintained gas levels at 0.1% O2. The inserts
were then transferred into deoxygenated BSS and placed back into
the tank at 0.1% oxygen for 90 min. After OGD, the slices were
immediately transferred into pre-warmed serum-free Neurobasal
supplemented with B27 without antioxidants in the presence or
absence of LCAR (5 mM) under normal O2 conditions.

post HI [6]. However, it is unclear how HI disrupts carnitine
homeostasis in the neonatal brain nor is it well understood how the
neuroprotection by LCAR supplementation is mediated. To begin
to elucidate these mechanisms, we utilized neonatal rat hippocampal slice cultures exposed to oxygen glucose deprivation
(OGD) as an in vitro model of neonatal HI to evaluate alterations
in carnitine homeostasis, and the effect of LCAR supplementation
on mitochondrial function, cell viability, and neuronal signaling.
Our data indicate that OGD decreases CPT1 and CPT2
protein levels and this is prevented by LCAR supplementation.
LCAR supplementation also restored the AC:FC ratio and this
attenuated the decrease in mitochondrial dysfunction associated
with OGD. Further, the preservation of mitochondrial viability
prevented the induction of apoptosis in the slice cultures and
preserved the functional activity of synaptic pathways within the
hippocampus after OGD.

Materials and Methods
Ethics Statement
All animal work was conducted according to national guidelines
for the ethical treatment of animals in research. All animal
protocols were approved by the institutional review boards of the
University of Montana and Georgia Health Sciences.

Hippocampal Slice Preparation and Induction of Oxygen
Glucose Deprivation

Real-time RT-PCR analysis

Neonatal rats (Sprague-Dawley) at postnatal Day 7 (P7) were
decapitated and the hippocampi dissected out under sterile
conditions. The hippocampi were cut into 400 mm slices using
a McIlwain tissue chopper and individual slices were cultured on
Millicell permeable membranes (0.4 mM pore size) in six well

Real-time RT-PCR was employed to evaluate changes in the
levels of CTP-1 and CTP-2 mRNA in response to OGD. All
primers used were designed by Primer 3. The sequences were
CTP-1: forward 59- GGAGACAGACACCATCCAACATA-39;

Figure 1. Oxygen glucose deprivation disrupts carnitine homeostasis in rat hippocampal slice cultures. Rat hippocampal slice cultures
were exposed to OGD in the presence or absence of L-carnitine (LCAR, 5 mM, 2 h prior to OGD). Slices were harvested 2 h after OGD and Protein
extracts (50 mg) were subjected to Western blot analysis to determine effects on CPT1 (A), CPT2 (B), and CrAT (C) protein levels. A representative blot
is shown in the inset of each panel. Two hours after OGD total RNA was also isolated and mRNA levels for CTP1 (D) and CTP2 (E) were determined by
SYBR Green real-time RT-PCR analyses. Both protein and mRNA expression was normalized using b-actin. In addition, the effect of OGD, in the
presence and absence of LCAR, on free carnitine levels (FC, F) and the acylcarnitine (AC): FC ratio (G) was determined. Data are presented as mean 6
S.E from 3 independent experiments using 60 pooled slices per experiment. * = P ,0.05 vs. no OGD; { = P,0.05 vs. OGD alone.
doi:10.1371/journal.pone.0040881.g001
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Figure 2. LCAR attenuates the increases in superoxide generation in rat hippocampal slice cultures exposed to oxygen glucose
deprivation. Rat hippocampal slice cultures were exposed to OGD in the presence or absence of L-carnitine (LCAR, 5 mM, 2 h prior to OGD).
Fluorescent imaging was then utilized to determine changes in DHE oxidation as a measure of total superoxide levels. Slices were then incubated
with DHE (20 mM, 20 min) at 2-, 6-, 12- and 24-h after OGD. Representative images are shown for 2 h (A). The effect of LACR pre-treatment alone on
cellular superoxide levels was also determined with representative images shown (B). Data are presented as mean 6 S.E. using 9–18 slices. * = P,0.05
vs. no OGD; { = P,0.05 vs. OGD alone.
doi:10.1371/journal.pone.0040881.g002

USA), using 2 ml of RT product, 12.5 ml of QuantiTect SYBR
Green PCR Master Mix (Qiagen), and primers (400 nM) in a total
volume of 25 ml. The following thermocycling conditions were
employed: 95uC for 10 min, followed by 95uC for 30 s, 55uC for
60 s, and 72uC 30 s for 45 cycles. The threshold cycles (Ct) of
a serially diluted control sample were plotted to generate
a standard curve. The concentration of each sample was
calculated by interpolating its Ct on the standard curve and then
normalized to b-actin (housekeeping gene) mRNA levels.

reverse, 59-AGGTGATGGACTTGTCAAACC-39; CTP-2: forward, 59-TCCTCGATCAAGATGGGAAC-39; reverse, 59GATCCTTCATCGGGAAGTCA-39; b-actin forward, 59CTCTTCCAGCCTTCCTTCCT-39; reverse, 59-GGGCAGTGATCTCTTTCTGC-39. Real-time RT-PCR was carried out
in two steps. First, total RNA was extracted from cells using the
RNeasy kit (Qiagen, Valencia, CA, USA), and 1 mg of total RNA
was reverse-transcribed using the QuantiTect Reverse Transcription Kit (Qiagen) in a total volume of 20 ml. Quantitative real-time
PCR was conducted on an Mx4000 (Stratagene, La Jolla, CA,

Western Blot Analysis
Protein extracts were prepared by homogenizing hippocampal
slices (4–15 slices were pooled for each determination) in 50 mM
Tris-HCl, pH 7.6, 0.5%Triton X-100, 20% glycerol containing
HaltTM protease inhibitor cocktail (Pierce Laboratories, Rockford,
IL). The extracts were then subjected to centrifugation (15,000 g x
15 min at 4uC). Supernatant fractions were assayed for protein
concentration using the Bradford reagent (Bio-Rad, Richmond,
CA) and used for Western blot analyses. Protein extracts (50 mg)
were separated on Long-Life 4–20% Tris-SDS-Hepes gels
(Frenchs Forest, Australia) and electrophoretically transferred to
Immuno-Blot PVDF membrane (Bio-Rad Laboratories, Hercules,
CA). The membranes were blocked with 5% nonfat dry milk in
Tris-buffered saline containing 0.1% Tween 20 (TBST). After
blocking, the membranes were probed with antibodies to CrAT
(Santa Cruz Biotechnology, Inc.), CPT1 (Affinity Bioreagents),
CPT2 (Affinity Bioreagents), HIF-1a (Abcam), AMPKa2 (Millipore), phospho-AMPKaTh172 (Millipore), or cleaved caspase 9
(CC-9, Cell Signaling). Reactive bands were visualized using
chemiluminescence (SuperSignalH West Femto Substrate Kit,
Pierce Laboratories, Rockford, IL) on a Kodak 440CF image
station (Kodak, Rochester, NY). Band intensity was quantified
using Kodak 1D image processing software. Each protein was
normalized by reprobing with b-actin (Sigma, St.Louis, MO).

Figure 3. LCAR attenuates the loss of metabolic viability in rat
hippocampal slice cultures exposed to oxygen glucose deprivation. Rat hippocampal slice cultures were exposed to OGD in the
presence or absence of LCAR (5 mM, 2 h prior to OGD). Slices were then
incubated with calcein AM (30 mM, 30 min) to estimate changes in
metabolic viability. Calcein AM staining was carried out at 2-, 6-, 12-, 24and 48-h after OGD. Representative images are shown for 2 h (A). Data
are presented as mean 6 S.E using 5–9 slices (B). * = P,0.05 vs. no OGD;
{ = P,0.05 vs. OGD alone.
doi:10.1371/journal.pone.0040881.g003
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Figure 4. LCAR attenuates the loss of mitochondrial membrane potential in rat hippocampal slice cultures exposed to oxygen
glucose deprivation. Rat hippocampal slice cultures were exposed to OGD in the presence or absence of LCAR (5 mM, 2 h prior to OGD). Slices
were then incubated with Rhodamine-123 (10 mM, 20 min) 2-, 6-, 12-, 24- and 48-h after OGD to estimate changes in mitochondrial membrane
potential. Representative images are shown for 2 h (A). ATP in the slice cultures was also determined (B). Data are presented as mean 6 S.E using 7–9
slices. * = P,0.05 vs. no OGD; { = P,0.05 vs. OGD alone.
doi:10.1371/journal.pone.0040881.g004

X area) measurement. All values obtained were normalized to the
untreated control mean and expressed as a percent change.

Measurement of Free and Total Carnitines
Detection of carnitines was performed using a Shimadzu UFLC
purifier system with a 5 mm Omnispher C18 column
(25064.6 mm OD) and equipped with a RF-10A XL fluorescence
detector (Shimadzu, Tokyo, Japan). Total and free carnitines levels
were quantified in the hippocampal slices by fluorescence detection at 248 nm (excitation) and 418 nm (emission).
Homogenate preparation. Hippocampal slices (60 per
group) were weighed and homogenized in 1:4 volumes of 0.5 M
HClO4. All samples were then centrifuged at 12,000 rpm
(,13,000 g) in an microcentrifue for 20 min. The pellet was
discarded and the supernatant neutralized to pH 7.0 with 3 M
KHCO3. These were subsequently used as homogenates.

Quantification of Slice Culture Cell Death using
Propidium Iodide uptake
Propidium iodide (PI, Molecular Probes) uptake was utilized to
determine decreases in overall neuronal death associated with
OGD. Neonatal hippocampal brain slices were incubated with PI
(100 ng/ml) for 24 h then washed 3 times with pre-warmed PBS
without calcium or magnesium. Slice cultures were then examined
prior to OGD using fluorescent microscopy with detection at
518 nm (excitation) and 604nm (emission). Slices showing distinct
PI labeling at this stage were deemed damaged and were then
excluded from further study. Slice culture images were obtained at
0-, 4- 8-, and 24 h after OGD using a 10-bit monochrome
fluorescence camera (HAMAMATSU Digital Camera C4742-95,
Hamamatsu, Japan), and processed with Image-Pro Plus6.0
(Media Cybernetics, Maryland, U.S.A.). The exposure time was
set at 200 ms, using a 4x magnification to capture the entire slice.
The evaluation of cell death was performed using a modification of
the method of Cronberg [14]. The fluorescent intensity was
reported using IOD (average density X area) measurement. All
values obtained were normalized to the untreated control mean
and expressed as percent change.

Sample purification and derivatization before HPLC
detection. For free carnitine (L-carnitine and acetyl L-carnitine)

determination- 300 ml homogenate, 100 ml water and 100 ml of
internal standard (Sigma ST 1093) were mixed. For total carnitine
determination- 300 ml homogenate were hydrolyzed with 0.3 M
KOH, heated at 80uC for 20 min, pH neutralized using perchloric
acid and 100 ml internal standard was added. All samples were
purified using solid phase extraction columns, SAX 100 mg/ml
(Varian, Harbor City, CA) and derivatized using 1-aminoanthracene in presence of EDCI (catalyst) and kept at 30uC for 1 hour to
complete reaction of carnitines. Separation on HPLC was carried
out with an isocratic elution in 0.1 M Tris-acetate buffer (pH 3.5):
acetonitrile (68:32, v/v) at a flow rate of 0.9 ml/min.

Estimation of Mitochondrial Metabolic Viability
The functional activity of mitochondrial esterases was determined by Calcein AM staining. Rat hippocampal slices were
incubated with Calcein AM (30 mM, Molecular Probes) for
30 min, washed 3 times with pre-warmed PBS without calcium
or magnesium, and fluorescent images captured using 506 nm
(excitation) and 529 nm (emission) and the 4X objective lens. The
fluorescent intensity of captured images was quantified in Image
Pro Plus using the IOD (average density X area) function. All
values obtained were normalized to the untreated control mean
and expressed as a percent change.

Measurement of global and Mitochondrial Superoxide
levels
Total superoxide levels were estimated by dihydroethidium
(DHE) oxidation as we have previously described [11,12].
Mitochondrial superoxide levels were estimated using the oxidation of the MitoSOX fluorescent dye as we have described [13].
Briefly, rat hippocampal slices were incubated with DHE (20 mM,
Molecular Probes) or MITOSOX (40 mM, Molecular Probes) for
20–30 min, washed 3 times with pre-warmed PBS without
calcium or magnesium, and captured on an Olympus IX51
fluorescent microscope at 518 nm (excitation) and 518 nm
(emission) and the 4X objective lens. The fluorescent intensity
was quantified in Image Pro Plus using the IOD (average density

PLOS ONE | www.plosone.org

Measurement of Mitochondrial Membrane Potential
Mitochondrial membrane potential (MMP) was measured over
time by staining rat hippocampal slice cultures with Rhodamine123 (Molecular Probes). Slices were preloaded with Rhodamine4
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Figure 6. Effect of LCAR supplementation on the neuronal cell
death associated with oxygen glucose deprivation in rat
hippocampal slice cultures. Rat hippocampal slice cultures were
exposed or not to OGD in the presence or absence of LCAR (5 mM) and
PI (100 ng/ml). The LCAR was added 2 h prior to OGD and maintained
throughout the exposure, washed out after OGD, or added post-OGD.
Images were then captured 24 h post-OGD. Representative images are
shown. Data are presented as mean 6 S.E using 6–8 slices. * = P,0.05
vs. no OGD; { = P,0.05 vs. OGD alone.
doi:10.1371/journal.pone.0040881.g006

Measurement of Caspase Activation
Twenty-four hours post-OGD caspase activation was measured
by exposing slices to the caspase activation reagent (10 mM,
Promega) for 20 min. Slices were then washed 3 times with prewarmed PBS without calcium or magnesium, and images captured
using fluorescent microscopy with detection at 506 nm (excitation)
and 529 nm (emission) using the 4X objective lens. The
fluorescent intensity was quantified in Image Pro Plus using
IOD (average density x area) function. All values obtained were
normalized to the untreated control mean and expressed as
a percent change.

Figure 5. LCAR attenuates mitochondrial superoxide induced
by oxygen glucose deprivation in rat hippocampal slice
cultures. Rat hippocampal slice cultures were exposed to OGD in
the presence or absence of LCAR (5 mM, 2 h prior to OGD). Slices were
then incubated with MitoSOX fluorescent dye (40 mM, 30 min) to
estimate changes in mitochondrial superoxide levels either after LCAR
pre-treatment (A) or 24 h post-OGD (B). Representative images are
shown. Data are presented as mean 6 S.E using 5–7 slices. * = P,0.05
vs. no OGD; { = P,0.05 vs. OGD alone.
doi:10.1371/journal.pone.0040881.g005

Measurement of Apoptotic Cell Death
Apoptotic neuronal death was measured by TUNEL staining
(Promega). Slices were fixed in 4% paraformaldehyde for 20 min
at room temperature, rinsed in PBS three times and removed from
the Millicell inserts, placed on glass slides. and processed according
to the manufacturer’s instructions. Images were captured using
fluorescent microscopy with detection at 506 nm (excitation) and
529 nm (emission) using the 4X objective lens and analyzed using
ImagePro software. All values obtained were normalized to the
untreated control mean and expressed as a percent change.

123 (10 mM) 20 min prior to image capture. Slices were washed
3 times with pre-warmed PBS without calcium or magnesium and
images captured using fluorescent microscopy with detection at
518 nm (excitation) and 604 nm (emission). The fluorescent
intensity of images was quantified in Image Pro Plus using the
IOD (average density X area) function. All values obtained were
normalized to the untreated control mean and expressed as
a percent change.

PLOS ONE | www.plosone.org

Electrophysiology/field recording
Slices were separated and placed in artificial cerebral spinal
fluid (ACSF) containing (in mM): 126 NaCl, 2.5 KCl, 1.2 MgCl2,
2.4 CaCl2, 1.2 NaH2PO4, 11.4 glucose, and 21.4 NaHCO3,
saturated with 95% O2 and 5% CO2 (pH 7.3), and maintained
at 30uC. For recording, slices were transferred to a submersion
5
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Figure 7. LCAR attenuates the increase in apoptosis induced by oxygen glucose deprivation in rat hippocampal slice cultures. Rat
hippocampal slice cultures were exposed to OGD in the presence or absence of LCAR (5 mM, 2 h prior to OGD). After 24 h slices were exposed to the
fluorescent caspase activation reagent (10 mM, 20 min) to estimate changes in caspase activity (A). Representative images are shown. Protein extracts
(50 mg) were also subjected to Western blot analysis to determine effects on cleaved caspase 9 (CC-9). Each gel was normalized for loading using bactin. Slices were also analyzed for TUNEL positive nuclei (C). Data are presented as mean # S.E using 8 slices. * = P,0.05 vs. no OGD; { = P,0.05 vs.
OGD alone.
doi:10.1371/journal.pone.0040881.g007

type recording chamber constantly perfused (1.9 ml/min) with
saturated ACSF at 30uC. Field excitatory post synaptic potentials
(fEPSPs) were recorded in stratum radiatum of CA1 using glass
stimulating and recording microelectrodes filled with HEPES
buffered ACSF (pH 7.3). EPSPs were monitored at 0.05 Hz and
were recorded using a Molecular Devices amplifiers interfaced to
a Digidata 1200 analog/digital converter. Control and analysis
was performed using AxographX (Version 1.0) or pClamp9
(Molecular Devices) software.

Results
L-carnitine supplementation ameliorates the OGDinduced disruption of carnitine homeostasis
CPT1 and CPT2 facilitate the transport of long-chain fatty
acids from cytosol into the mitochondrial matrix, the site of boxidation. Carnitine acetyl transferase (CrAT), which resides in
the matrix, is able to reconvert the short- and medium chain acylCoAs into acylcarnitines using intra-mitochondrial carnitine.
Using hippocampal slice cultures exposed to oxygen glucose
deprivation (OGD), we initially examined the effect of OGD on
the protein levels of these three important mitochondrial proteins
involved in carnitine metabolism. Our data indicate that OGD
significantly decreases both CPT1 (,40% decrease, Fig. 1 A) and
CPT2 (,50% decrease, Fig. 1 B) protein levels and this decrease
was ameliorated by LCAR treatment (Fig. 1 A & B). We found no
effect of OGD or LCAR on the levels of the CrAT protein (Fig. 1
C). Changes in CPT1 and CPT2 protein were also reflected at the
mRNA level (D & E). To determine if the OGD mediated
alterations in CPT1 and CPT2 resulted in disruption of cellular
carnitine homeostasis, we measured free carnitine (FC) levels and
determined the acylcarnitine: free carnitine (AC:FC) ratio using

Statistical Analysis
All data was analyzed utilizing Prism software (GraphPad
Software, Inc., La Jolla, CA). One-way ANOVA with Tukey’s
post-hoc was used to determine statistical significance between
groups. Two-tailed, unpaired t-test was used to determine specific
differences between single groups. A p value of ,0.05 was
considered significant, and slices that were greater than 6 4
standard deviations from the mean were considered outliers and
omitted from statistical analyses.

PLOS ONE | www.plosone.org
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Figure 8. Affect of oxygen glucose deprivation and LCAR on survival factors in rat hippocampal slice cultures exposed to oxygen
glucose deprivation. Rat hippocampal slice cultures were exposed to OGD in the presence or absence of L-carnitine (LCAR, 5 mM, 2 h prior to
OGD). Slices were harvested 2 h after OGD and Protein extracts (50mg) were subjected to Western blot analysis to determine effects on HIF-1a (A),
AMPKa2 (B & C), and phospho-AMPK-Th172 (B & D) protein levels. Total AMPKa2 protein was normalized using b-actin. Data are presented as mean 6
S.E from 3 independent experiments using 60 pooled slices per experiment. * = P,0.05 vs. no OGD; { = P,0.05 vs. OGD alone.
doi:10.1371/journal.pone.0040881.g008

time points tested. This finding suggests LCAR treatment
significantly increased MMP above basal levels and this effect
correlated with a preservation of ATP levels in the slice culture
(Fig. 4 B). Further, we found that although LCAR supplementation increased mitochondrial-derived ROS prior to OGD (as
determined using MitoSOX fluorescence) (Fig. 5 A) there was
a significant decrease in mitochondrial superoxide generation 24 h
post-OGD (Fig. 5 B).

HPLC analysis. Our data indicate that OGD alone caused
a significant decrease in FC levels (Fig. 1 F). LCAR supplementation prior to OGD increased the levels of FC (Fig. 1 F). Further,
we found that OGD significantly increased the AC:FC ratio.
However, this effect was prevented by LCAR (Fig. 1 G). The
preservation of carnitine metabolism correlated with a decrease in
total cellular oxidative stress post-OGD (as determined by DHE
oxidation) (Fig. 2 A). However, DHE oxidation was significantly
increased by LCAR treatment prior to OGD (Fig. 2 B).

LCAR supplementation reduces neuronal cell death in rat
hippocampal slice cultures exposed to OGD

LCAR supplementation maintains mitochondrial function
in rat hippocampal slice cultures exposed to OGD

We next determined if the LCAR-mediated preservation of
mitochondrial function could attenuate the neuronal cell death
associated with OGD. Our data indicate that LCAR supplementation prior to OGD decreased PI uptake in slice cultures exposed
to OGD (Fig. 6). However, this protection was lost if the LCAR
was removed prior to OGD (Fig. 6). Further, if LCAR was added
only post-OGD the PI uptake was enhanced indicating increased
cell death was occurring (Fig. 6). We next evaluated the effect of
LCAR supplementation on apoptotic signaling events. Using
a fluorescent assay for pan-caspase activation, we found that
LCAR supplementation significantly inhibited overall caspase
activation 24 h post-reperfusion (Fig. 7 A). To further elucidate
this effect, we examined mitochondrially cleaved (activated)
caspase 9 (CC-9). CC-9 is a major component of mitochondrial
mediated caspase activation after hypoxic insult [5]. Using
Western blot analysis, we found that LCAR supplementation
significantly decreased the levels of CC-9 (Fig. 7 B). To ensure that
LCAR mediated decreases in caspase activation correlated with
decreased apoptosis, fixed hippocampal slices 24 h post-OGD
were assayed for TUNEL staining. Our data indicate that LCAR
supplementation significantly decreased TUNEL staining of
neurons 24 h post reperfusion (Fig. 7 C).

To measure the effect of LCAR supplementation on mitochondrial function after OGD, cultures were assayed with Calcein AM,
a fluorogenic esterase substrate that is retained and cleaved in
neurons that are metabolically active. Utilizing this dye, the effect
of mitochondrial metabolic viability was assayed in slice cultures at
2–48 h (Fig. 3) after OGD. Slices exposed to OGD exhibited an
irreversible decrease in metabolic activity (decreased fluorescence)
that was attenuated in the LCAR treated slices (Fig. 3). LCAR
treatment in non-OGD slices also resulted in an increase in
Calcein AM fluorescence suggesting LCAR not only prevents
mitochondrial dysfunction but also increases metabolic activity
prior to OGD (Fig. 3 A). To further evaluate the effect of LCAR
supplementation on mitochondrial function we next examined the
effect on mitochondrial membrane potential (MMP) after OGD.
Utilizing Rhodamine-123 fluorescent staining, mitochondrial
membrane potential was measured at 2–48 h (Fig. 4 A) postOGD. At 2 h Rhodamine-123 fluorescence was increased in all
groups compared to control slices (Fig. 4 A). However, Rhodamine-123 staining was significantly decreased at 6-, 12-, 24- and
48-h post-OGD indicating mitochondrial depolarization in
neurons (Fig. 4 A). In contrast, carnitine supplemented slices
exposed to OGD showed MMP depolarization 12-h post-OGD
(Fig. 4 A), but demonstrated a complete recovery (basal repolarization compared to non-OGD control slices) of MMP at 24and 48-h post-OGD (Fig. 4 A). Slice cultures exposed to LCAR
alone had a significant increase in Rhodamine-123 staining at all
PLOS ONE | www.plosone.org
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To determine if LCAR was modulating the levels of other
proteins that could modulate neuronal survival we evaluated
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Figure 9. LCAR maintains synaptic viability in the CA1 region after oxygen glucose deprivation. Rat hippocampal slice cultures were
exposed to OGD in the presence or absence of LCAR (5 mM, 2 h prior to OGD). Representative recordings of Schaffer collateral-CA1 pyramidal neuron
field EPSPs made 48 h following OGD (A). Data are presented as mean 6 S.E from 4 independent experiments using 3–5 slices per experiment (B).
* = P,0.05 vs. no OGD; { = P,0.05 vs. OGD alone.
doi:10.1371/journal.pone.0040881.g009

that OGD significantly decreased field excitatory postsynaptic
potential (fEPSP) amplitudes (Fig. 9 A). In contrast, LCAR treated
slices protected synaptic viability, as responses following OGD in
the presence of LCAR were not significantly different from the
untreated controls 48 h post reperfusion (Fig. 9 B). These data
suggest LCAR not only decreased neuronal death, but also
preserved synaptic transmission after OGD.

changes in HIF-1a and AMPKa2. Our data indicate that OGD
significantly increased both HIF-1a (Fig. 8 A) and AMPKa2 (Fig. 8
B & C). LCAR supplementation significantly decreased the OGDmediated increase in HIF-1a (Fig. 8 A) but had no affect on the
increase in AMPKa2 (Fig. 8 B & C). LACR supplementation in
the absence of OGD also increased HIF-1a but to a much lesser
extent than OGD (Fig. 8 A). In addition, although phosphoAMPK-Th172 levels were increased by OGD (Fig. 8 B) when
normalized to total AMPKa2 (Fig. 8 B & C) there was no relative
change (Fig. 8 B & D). Again LCAR supplementation had no
affect of the relative levels of phospho-AMPK-Th172 (Fig. 8 D).

Discussion
The mitochondrial membrane is impermeable to long-chain
fatty acids and the transport of these fatty acids across
mitochondrial membrane is mediated by the enzymes: CPT1
and CPT2 [4,15,16]. CPT1 is localized in the outer mitochondrial
membrane and conjugates carnitine with long-chain acyl-CoA to
make acylcarnitines. At the inner mitochondrial membrane, CPT2
transesterifies acylcarnitines back to free carnitine and long-chain
acyl CoA [6,17,18]. Thus, transfer of fatty acids into the
mitochondria for b-oxidation is dependent on the function of
CPT1 and CPT2 and therefore the decreases in their expression
mediated by OGD would disrupt b-oxidation. This could explain
the disruption in energy metabolism in the mitochondria as fatty

LCAR supplementation protects synaptic transmission in
rat hippocampal slice cultures exposed to OGD
While experimental data obtained from slice cultures demonstrated a link between LCAR treatment and decreased cell death,
these data did not assess the viability and synaptic function of
LCAR treated neurons. To address this issue, LCAR supplemented cultures were exposed to OGD and field recording experiments were performed to measure excitatory transmission.
Measurement of synaptic transmission in slice cultures showed
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HIF-1a was increased in presence of LCAR, but was significantly
lower when compared to slices exposed to OGD. The role of HIF1a in cerebral ischemic events is complex. As a hypoxia induced
transcription factor, HIF-1 allows the cellular adaptation to low
oxygen conditions via the regulation of multiple target genes, some
of which are involved in glucose metabolism and transport. HIF1a can induce a glycolytic shift (the Warburg effect) that allows
cells to generate ATP independently of oxidative phosphorylation
in the mitochondria [34]. This may explain our finding that ATP
levels are maintained after OGD in LCAR supplemented slice
cultures after OGD. In contrast, studies have shown that HIF-1
plays a detrimental role in ischemic reperfusion injury. HIF-1 has
been shown to induce the pro-apoptotic factors which can lead to
mitochondrial dysfunction and cell death [35]. The duality of
HIF-1 may be related both to the level of HIF-1 protein in a cell
and the duration of the induction [35]. Thus, the modest increase
in HIF-1 induced by LCAR prior to OGD may activate protective
signaling pathways that, by attenuating the OGD-mediated large
increase in HIF-1, may preserve neuronal function. However,
further, studies involving the modulation of HIF-1 activity will be
required to test this hypothesis.
Our data also indicated that LCAR exerted a biphasic effect on
MMP. MMP levels were found to decrease 6- and 12 h postreperfusion, but returned to basal levels at 24- and 48-h. This
finding suggests LCAR treated cultures are capable of selectively
modulating MMP after OGD. This finding could be important as
synaptic transmission is rapidly attenuated by HI and after
reperfusion it briefly returns only to decrease as the secondary
phase of energy depletion occurs [36,37]. Previously it has been
demonstrated that a percentage of neurons exposed to mild HI will
not undergo cell death, but are unable to generate functional
EPSP’s due to acute mitochondrial dysfunction and ATP depletion
[38,39]. However, our data demonstrate that LCAR supplemented slices generated considerably more robust EPSP amplitudes
(,300 mV vs. 75 mV) after OGD and these did not significantly
differ from control slices. The preservation of the synaptic
transmission in LCAR exposed slices after OGD may be linked
to its ability to restore mitochondrial function 24 h postreperfusion. Our data also show that LCAR attenuates the
increase in cleaved caspase 9 (CC-9) levels after OGD. Thus, it is
unlikely that activation of the mitochondrial permeability transition pore (MPTP) is occurring in LCAR treated slices [15,40].
Indeed when the mitochondrial membrane is disrupted the release
of cytochrome C leads to increased levels of CC-9 [40]. A possible
explanation for the decrease and return of MMP may be linked to
activation of mitochondrial uncoupling proteins (UCP’s). UCP’s
are a class of reversible protein pores that serve to uncouple
(reduce) the proton motive force by allowing protons to pass back
into the inner mitochondrial membrane without generating ATP
and increasing ROS levels [41,42]. This activity has been shown
to increase the efflux of calcium, and exert a neuroprotective effect
in neurons exposed to OGD [41]. Activation of UCP’s has been
shown to significantly decrease ROS levels, reduce membrane
damage, and induce mitochondrial fission as a compensatory
effect [41,43]. However, future studies will be required to
determine if UCP proteins are involved in the neuroprotective
effect exerted by LCAR.
In conclusion our data indicate that LCAR supplementation
acts to prevent the disruption of carnitine homeostasis through two
interconnected pathways. It prevents the OGD-mediated decrease
in CPT1 and CPT2 expression and induces an ischemic
preconditioning effect in neurons that protects the MMP and
prevents the induction in apoptosis during the reperfusion injury
post-OGD. As neonatal HI is marked by profound mitochondrial

acids are the most important metabolic fuel under fasting or stress
conditions, especially in neonates. Further, prior studies have
found that low FC levels and high AC levels in neonates exposed
to HI [19,20]. Although a recent study has shown that
mitochondrial CPT1 level and b-oxidation of fatty acids were
significantly reduced in muscle and liver of rats exposed to coldhypobaric hypoxic environment [21] this is the first study
indicating that OGD decreases the expression of CPT1 and
CPT 2 in organotypic slice cultures. However, the regulation of
CPT1 by oxygen may be cell type dependent as a recent study has
shown that CPT1 is increased by hypoxia or glucose deprivation
in tumor cells [22]. The increase in CPT1 involved AMPKa.
However, in our organotypic slice cultures although we observed
an increase in AMPKa protein levels there were no changes in
phopsho-AMPK-Th172 and a decrease in CPT1 again suggesting
cell specific events may be involved.
HI in the newborn disrupts energy metabolism in mitochondria
and it is likely that LCAR limits the reperfusion injury after
hypoxia by preventing long-chain acyl-CoA accumulation and
subsequent production of ROS by damaged mitochondria. In
previous studies it has been shown that LCAR treatment increases
cellular respiration, and, as a byproduct, increased superoxide
production [23,24]. Our data confirm this observation as we found
DHE oxidation to be significantly elevated in LCAR treated slices
prior to exposure to OGD. LCAR supplementation prior to OGD
did not increase basal ATP levels. However, during postreperfusion LCAR supplementation significantly reduced DHE
oxidation and maintained basal levels of ATP, suggesting that
there was a reduction in oxidative stress and a preservation of
metabolic viability. Furthermore, using MitoSOX to estimate
mitochondrial levels of superoxide we found the same result:
carnitine treatment increased mitochondrial superoxide levels
prior to OGD while reducing mitochondrial superoxide, enhancing mitochondrial function and attenuating neuronal death postOGD.
Pre-treatment with LCAR increased markers of mitochondrial
metabolic viability and mitochondrial membrane potential (MMP)
prior to OGD. This is in agreement with previous studies from
Ames et al demonstrating LCAR treatment increases ATP and
ROS within the mitochondria as a result of increased fatty acid
transport [24,25,26,27]. It may appear paradoxical that increasing
ROS prior to OGD would have a neuroprotective effect as it is
widely accepted that neuronal mitochondria lack robust antioxidant defense systems and are highly sensitive to lipid membrane
damage associated with increased ROS levels [28]. However, it is
possible that LCAR pre-treatment, by combining increases in
ATP and ROS under basal conditions, may be acting as a type of
ischemic pre-conditioning in which neurons exposed to a mild
insult are protected against a full insult. Support for LCARmediated pre-conditioning also comes from our data in which we
found that the addition of LCAR post-OGD exacerbated neuronal
cell death. If LCAR causes an oxidative insult, albeit a mild form,
this would be deleterious in the presence of a severe insult.
Although our data do not allow us to delineate the mechanism by
which this pre-conditioning is occurring, it may be mediated by an
LCAR-dependent increase in anti-oxidant enzyme capacity.
Studies have demonstrated that mild ischemia can upregulate
SOD1, SOD2 and catalase in hippocampal tissue [29,30].
Blocking this effect with an antisense to SOD1 significantly
decreases the neuroprotective effect [31,32,33]. Thus, LCAR may
exert its protective effect by increasing antioxidant expression in
the mitochondria.
Our data also demonstrated that the increase in HIF-1a
induced by OGD was attenuated by LCAR supplementation.
PLOS ONE | www.plosone.org
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dysfunction that results in neuronal loss and neurological deficits,
we speculate that as LCAR represents a compound that prevents
mitochondrial dysfunction. Thus, it may have significant clinical
relevance in treating neonatal HI. It can be administered both to
pregnant females and infants in high doses with no measureable
side effects or toxicity [44,45]. As a possible prophylaxis for
neonatal HI, we suggest that carnitine is a neuroprotective
compound that warrants further investigation.
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